Blocking either PD-L1 or PD-1 can impede their binding, hence hindering T cells from receiving the immunosuppressive signal to maintain their activation and proliferation state, and then rendering T cells to perform the task of killing tumor cells. The gene discussed is PDCD1; the disease is neoplasm.